Mechanistically, TGFB signalling via the TGFBR2–SMAD1 axis regulates expression of the tumour suppressor sphingosine-1-phosphate receptor (S1PR2), controlling DLBCL survival in vitro and restricting tumour growth in vivo [70]. Here, S1PR2 is linked to neoplasm.